3136 results for «2836»
3136 results
What's new in bifurcations - A closer look on optimisation techniques
17 May 2022 – From EuroPCR 2022
Treatment dilemma: the failure of provisional strategy
17 May 2022 – From EuroPCR 2022
Primary PCI: new issues, new solutions
19 May 2022 – From EuroPCR 2022
What's new in intravascular imaging - a closer look on the real-life use of OCT/IVUS
17 May 2022 – From EuroPCR 2022
Daily news
17 May 2022 – From EuroPCR 2022
Complex heart problems in cancer patients
19 May 2022 – From EuroPCR 2022
TAVI and thrombocytopenia, TAVI, CAD and hepatocarcinoma, or even severe aortic regurgitation and ovarian cancer with infective endocarditis: analyze the case of different cancer patients to be treated for cardiac pathologies in this session from EuroPCR 2022.
What's new for calcified lesions - a closer look on plaque modification
18 May 2022 – From EuroPCR 2022
Treatment dilemma - pearls and pitfalls of treating calcified lesions
18 May 2022 – From EuroPCR 2022
What's new in bifurcations - a closer look on Culotte and DK Crush
18 May 2022 – From EuroPCR 2022
Intervention in end stage heart failure: LVAD complications and pressure control
19 May 2022 – From EuroPCR 2022
Treatment dilemma: when is the 2nd stent needed in bifurcation PCI?
18 May 2022 – From EuroPCR 2022
What's new in treatment of stent failure - a closer look at stent restenosis and thrombosis
This session shows cases from daily practice that illustrate the problems of stent failure from a general perspective. It allows for a better understanding of the mechanisms of stent restenosis & thrombosis on the one hand, and the role of DCBs on the other.
Daily news
18 May 2022 – From EuroPCR 2022
How should I treat ostial circumflex restenosis?
19 May 2022 – From EuroPCR 2022
Consider how to treat circumflex restenosis after a left main crossover stent and circumflex restenosis after left main PCI with 2 stents and try to learn from the two cases presented in this session: what are the ostial circumflex restenosis mechanisms, and the treatment options? What...
Secondary mitral regurgitation: when and how to treat
19 May 2022 – From EuroPCR 2022
Watch a 46-year-old patient from Toulouse presenting a congestive heart failure syndrome with a severe secondary mitral regurgitation being treated live!
Image-guided bifurcation stenting - In vitro beating heart simulation-based learning from Japan
18 May 2022 – From EuroPCR 2022
The focus of this EuroPCR 2022 session is on complex bifurcation intervention: learn a step-wise approach using imaging in a bifurcation stenting strategy, acknowledge the geographical differences in the way we approach these techniques, and experience the use of simulation-based learning on an in vitro beating...
Endovascular aortic arch aneurysm treatment
17 May 2022 – From EuroPCR 2022
Watch this session to gain insight into the treatment of endovascular aortic arch aneurysm, thanks to a selection of challenging cases: the percutaneous device closure of a leaking descending aortic pseudoaneurysm, an ascending aortic pseudoaneurysm closure with a vascular plug, and more!
Treating diverse mitral regurgitation anatomies: the power of versatility
16 May 2023 – From EuroPCR 2023
Based on a LIVE mitral TEER educational procedure and several case examples, this MR patient session will allow you to learn more about the PASCAL platform and system, as well as the latest clinical and real-world data on mitral TEER using the PASCAL system, while benefiting...
Coronary Sinus Reducer: insights into treating refractory angina patients with obstructive and non-obstructive coronary artery disease
16 May 2023 – From EuroPCR 2023
Watch this session to learn how Sinus Reducer may relieve angina by increasing pressure in the coronary sinus, and how it was associated with significant improvement in symptoms and quality of life, as long as the different steps of this simple procedure are dully followed and...
Cutting-edge technologies: clinical updates on TES, BRS, TAVR and LAA closure
17 May 2023 – From EuroPCR 2023
Watch this session to find out more about the three-year outcomes of the FUTURE-II Trial, the TARGET clinical trial roadmap, the TARGET IV NA Trial update, the twelve-month outcomes of the SAVE PROTECT Trial, and the quantitative aortographic assessment of regurgitation in patients treated with VitaFlow.
